company background image
RHO6 logo

Roche Holding DB:RHO6 Stock Report

Last Price

€35.00

Market Cap

€227.4b

7D

-1.4%

1Y

14.2%

Updated

07 Nov, 2024

Data

Company Financials +

RHO6 Stock Overview

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania.

RHO6 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends5/6

Roche Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Roche Holding
Historical stock prices
Current Share PriceCHF 35.00
52 Week HighCHF 38.50
52 Week LowCHF 27.10
Beta0.15
11 Month Change0.79%
3 Month Change-2.98%
1 Year Change14.19%
33 Year Change-21.15%
5 Year Change3.40%
Change since IPO236.54%

Recent News & Updates

Recent updates

Shareholder Returns

RHO6DE PharmaceuticalsDE Market
7D-1.4%-1.9%-1.4%
1Y14.2%-15.7%11.8%

Return vs Industry: RHO6 exceeded the German Pharmaceuticals industry which returned -15.7% over the past year.

Return vs Market: RHO6 exceeded the German Market which returned 11.8% over the past year.

Price Volatility

Is RHO6's price volatile compared to industry and market?
RHO6 volatility
RHO6 Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement7.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: RHO6 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: RHO6's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1896103,605Thomas Schineckerwww.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas.

Roche Holding AG Fundamentals Summary

How do Roche Holding's earnings and revenue compare to its market cap?
RHO6 fundamental statistics
Market cap€227.39b
Earnings (TTM)€11.28b
Revenue (TTM)€64.36b

19.9x

P/E Ratio

3.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHO6 income statement (TTM)
RevenueCHF 60.58b
Cost of RevenueCHF 15.43b
Gross ProfitCHF 45.16b
Other ExpensesCHF 34.54b
EarningsCHF 10.62b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)13.33
Gross Margin74.54%
Net Profit Margin17.53%
Debt/Equity Ratio104.8%

How did RHO6 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

72%

Payout Ratio